Cervical cancer has emerged as the “fastest-rising” cancer in Canada, prompting urgent calls from healthcare professionals for the federal government to intensify its efforts to combat this growing crisis. During a press conference held in Ottawa by the Society of Gynecologic Oncology of Canada, experts highlighted the pressing need for more effective policies, despite the government’s 2025 action plan aiming to eradicate cervical cancer as a public health concern by 2040.
Dr. Shannon Salvador, president of the society, expressed concern over the alarming statistics surrounding cervical cancer diagnostics and mortality, declaring that the current situation represents a “silent national health crisis.” In 2025, approximately 1,650 Canadians were expected to be diagnosed with this preventable disease, with an estimated 430 fatalities attributed to it.
The Challenge of Prevention
Despite advancements in medical technology, Canada’s reliance on traditional Pap testing and the stagnation of human papillomavirus (HPV) vaccination rates have been cited as significant setbacks in combating cervical cancer. Dr. Salvador noted that the completion rate for the national HPV vaccination programme remains at a disappointing 64%, which falls far short of the levels necessary for effective prevention and elimination.
“This statistic is not merely a medical failure but a policy failure,” Dr. Salvador remarked, emphasising that Canada must reassess its approach to cervical cancer screening and prevention.
A Shift Towards Innovative Screening
In light of these challenges, the Society of Gynecologic Oncology is advocating for an immediate national transition to HPV DNA testing for cervical cancer screening. This includes the implementation of HPV self-collection kits, which could potentially broaden access to screening, particularly for those facing barriers such as geographical isolation, historical trauma, or a lack of healthcare providers.
Dr. Salvador highlighted the importance of these self-collection kits, stating that they could eliminate obstacles for individuals in rural, Indigenous, and underserved communities who often fall outside the reach of the healthcare system. “These barriers are not due to biology; they are rooted in a fragmented system that perpetuates health inequities,” she stated.
Addressing Health Disparities
Dr. Sarah Kean, the provincial lead for cervical cancer in Manitoba, underscored the disproportionate impact of cervical cancer on Indigenous women. She pointed out that these women are diagnosed at later stages and experience worse outcomes not because of biological factors, but due to systemic barriers and shortcomings in access to screening resources.
Kean called for robust measures to ensure universal access to HPV screening across Canada, advocating for federal legislation to support such initiatives. “Robust HPV screening must mean more than simply updating guidelines; it requires clear national standards and accessibility for all Canadians,” she asserted.
The Financial Implications
The economic burden of cervical cancer on the Canadian healthcare system is considerable, with treatment costs projected to reach $132 million in 2024 alone. Screening eligible Canadians would incur an additional cost of $106 million over a five-year period.
The Canadian Cancer Society has reported that cervical cancer remains a significant public health issue, ranking as the fourth most diagnosed cancer and the fourth leading cause of cancer-related mortality among females globally. Alarmingly, while other cancer incidences in Canada are decreasing, the rates of cervical cancer are stagnating, highlighting the urgent need for renewed focus and action.
Why it Matters
The current trajectory of cervical cancer rates in Canada poses a significant threat to public health, particularly for vulnerable populations. As healthcare advocates call for immediate reforms and improved access to screening, it is essential for policymakers to prioritise these changes. By addressing the systemic barriers that hinder access to cervical cancer prevention and care, Canada can move towards a future where this preventable disease is no longer a silent crisis, but one that is actively managed and ultimately eradicated. The health of countless Canadians relies on these decisive actions.
